DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Bitopertin is an investigational drug.
There have been 10 clinical trials for Bitopertin. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2010.
The most common disease conditions in clinical trials are Schizophrenia, Disease, and Compulsive Personality Disorder. The leading clinical trial sponsors are Hoffmann-La Roche, Niuvanniemi Hospital, and Karolinska Institutet.
Recent Clinical Trials for Bitopertin
|A Study of Bitopertin (RO4917838) in Adults With Non-Transfusion-Dependent Beta-Thalassemia||Hoffmann-La Roche||Phase 2|
|A Study Exmining the Effect of Multiple Doses of Bitopertin on the Single Dose Pharmacokinetics of Midazolam in Healthy Volunteers.||Hoffmann-La Roche||Phase 1|
|Sodium Benzoate for Treatment of Attenuated/Transient Psychosis. A Randomized Placebo-controlled Trial.||Karolinska Institutet||Phase 2|